Despite more than 40 years of research, our understanding of this field remains limited. Dr Douglas Packer joins the show to discuss the pathophysiology of atrial fibrillation in regard to the targets for radiofrequency ablation, how the procedure has changed in the past 15 years, and what complications are associated with the procedure. How will the CABANA trial contribute to the discourse?